Track 9: Biomarkers in Neuro-Oncology

Biomarkers are used to educate doctors on how to treat brain tumours. One application is to properly group tumours with similar hereditary/genomic characteristics and to arrange preparations separately for each gathering. The biomarker is used to predict patient reaction so that the optimum treatment for patients can be chosen based on their tumour characteristics. Given the relatively small numbers of individuals available for preliminaries, preliminary plans that pick unselected participants are insufficient for identifying treatments that are successful only in subsets of patients.



 


    Related Conference of Track 9: Biomarkers in Neuro-Oncology

    June 29-30, 2026

    37th Conference on Clinical Neuroscience and Neurogenetics

    Aix-en-Provence, France
    June 29-30, 2026

    39th European Neurology Congress

    London, UK
    July 20-21, 2026

    37th World Congress on Neurology and Neuroscience

    Amsterdam, Netherlands
    July 23-24, 2026

    14th International Conference on Cannabis & Medicinal Research

    Amsterdam, Netherlands
    September 18-19, 2026

    21st Annual Congress on Neuroscience

    Dubai, UAE
    November 16-17, 2026

    8th World Brain Congress

    Tokyo, Japan
    November 23-24, 2026

    16th Global Alzheimers Summit

    Paris, France
    December 21-22, 2026

    6th International Conference on Child Neurology

    Paris, France
    March 22-23, 2027

    8th International Conference on Neurologists

    Singapore City, Singapore

    Track 9: Biomarkers in Neuro-Oncology Conference Speakers

      Recommended Sessions

      Related Journals

      Are you interested in